BackFirst Tracks Biotherapeutics Overview

First Tracks Biotherapeutics Net Tangible Assets

First Tracks Biotherapeutics's net tangible assets is $150M.

Get informed when a big investor buys or sells

+ Follow
Net Tangible Assets
$151.01M

Peer trimmed avg / median

Loading

First Tracks Biotherapeutics Net Tangible Assets History

Loading

First Tracks Biotherapeutics vs. peers: Net Tangible Assets Comparison

Loading

First Tracks Biotherapeutics Net Tangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

First Tracks Biotherapeutics (TRAX) FAQ

First Tracks Biotherapeutics (TRAX) currently reports a net tangible assets of $150M as of September 2026. Use the charts on this page to explore First Tracks Biotherapeutics's net tangible assets history and peer comparisons.

First Tracks Biotherapeutics reported $150M in net tangible assets as of September 2026. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $150M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for First Tracks Biotherapeutics, and consider following TRAX for alerts when major investors trade the stock.

First Tracks Biotherapeutics is classified in the Healthcare sector. On net tangible assets, it currently shows $150M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing TRAX with unrelated industries.

Questions & Answers